SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
SEC Accession No. 0001193125-11-340337
Filing Date
2011-12-14
Accepted
2011-12-14 09:34:13
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE TO d271077dsctoia.htm SC TO-I/A 35889
2 PRESS RELEASE DATED DECEMBER 14, 2011 d271077dex99a5v.htm EX-99.(A)(5)(V) 9061
3 GRAPHIC g271077img001.jpg GRAPHIC 5330
  Complete submission text file 0001193125-11-340337.txt   54294
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799 (805)313-1762
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799 (805)313-1762
AMGEN INC (Subject) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A | Act: 34 | File No.: 005-34640 | Film No.: 111259938
SIC: 2836 Biological Products, (No Diagnostic Substances)